$BGMS

Bio Green Med Solution, Inc. (BGMS): Submission of Matters to a Vote of Security Holders

Bio Green Med Solution, Inc. (BGMS) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. false 0001130166 0001130166 2026-06-18 2026-06-18 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 June 18, 2026 D

Original reporting
Published Jun 22, 2026, 10:10 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 22, 2026, 10:31 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefCorporate actions
Primary signal
$BGMS
Neutral
high confidence
Mentioned
$BGMS
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$BGMSNeutralLow
01

Why it matters

This is a confirmation of corporate governance decisions (board and auditors) rather than a new operating or financial catalyst.

02

Market read

Governance vote results are typically low-volatility, but they can reduce uncertainty around board/auditor continuity.

03

What to watch

Traders may still want to check the referenced Proxy Statement for any contested items or changes not captured in the summarized vote table.

Relevance 6/10Novelty 3/10Timing: Filed June 22, 2026 (covers June 18, 2025 annual meeting results)

Background

The article is an SEC Form 8-K (Item 5.07) summarizing matters voted on at BGMS’s annual meeting, including director elections, auditor appointment, and an advisory compensation vote.

Company-level read

Ticker impact

$BGMSNeutralHigh confidence
Context

BGMS filed an 8-K reporting shareholder voting results, including director re-elections and ratification of independent auditors for fiscal 2026.

Expected impact

Low likelihood of a sustained price move solely from these vote results.

Evidence & confidence

The filing discloses standard annual meeting outcomes (director elections, auditor ratification, advisory compensation vote) without new financial guidance, transactions, or enforcement actions.

Market effects

No sector-level read-across; governance-only disclosure.

No clear regional market linkage beyond Nasdaq-listed microcap governance.

Minimal; standard SEC corporate action filing.

Counterpoint

Even routine vote outcomes can matter if they signal stability after prior governance concerns, but this filing provides no such context.

Key entities

  • Bio Green Med Solution, Inc.

    Nasdaq-listed registrant filing Item 5.07 8-K with annual meeting voting results.

  • SFAI Malaysia Plt.

    Named as independent auditors ratified for the fiscal year ending Dec. 31, 2026.

  • Dr. Satis Waran Nair Krishnan

    Elected as Class I director for a three-year term expiring at the 2029 annual meeting.

  • Inigo Angel Laurduraj

    Elected as Class I director for a three-year term expiring at the 2029 annual meeting.

Related articles

$BGMSMed

Bio Green Med Solution, Inc. (BGMS): Results of Operations and Financial Condition

Bio Green Med Solution, Inc. (BGMS) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 BIO GREEN MED SOLUTION Reports SECOND quarter financial results and provides business update KUALA LUMPUR, MALAYSIA, August 12, 2026 – Bio Green Med Solution, Inc. (NASDAQ: BGMS; “BGMS” or the “Company”), a diversified company engaged primarily in the provision of fi

$BGMSHighAI 9/10

Bio Green Med Solution Surges 172 % After Announcing Deal to Acquire Malaysia Waste Tech Company - Bio Gre

Bio Green Med Solution (NASDAQ:BGMS) shares rose about 123% to $2.35 after it signed an all-stock business combination agreement with Malaysia-based Future NRG. Future NRG will become a wholly owned BGMS subsidiary; the combined firm is expected to trade on Nasdaq under BGMS, led by Datuk Dr. Doris Wong Sing Ee. The deal is expected to close in Q4 2026, pending shareholder approval and SEC registration.

$CVXMedAI 8/10

Chevron (CVX) Supercharges its Venezuela Bet with More Oil Rigs

Chevron (CVX) plans to more than double its oil rigs in Venezuela, aiming to increase output to 600,000 barrels per day by 2031. The company has invested over $7 billion in joint ventures and expects low production costs below $20 per barrel. Despite risks, this expansion could significantly boost Chevron's earnings and cash flows, according to the company.

$CLFMedAI 8/10

How Investors Are Reacting To Cliffs Stock $1b Plant Upgrade

Cleveland-Cliffs announced a $1b modernization of its Middletown Works plant, supported by a $500m U.S. Department of Energy grant. The upgrade aims to improve efficiency and sustainability. The company reported a $866.0m loss and forecasts revenue growth of 6.6% annually, with earnings expected to improve to $1.1b by 2029. Analysts have set price targets ranging from $10.0 to $15.0, with a consensus target of $12.0.

$ZCSHMed

Grayscale Zcash ETF sets 3-for-1 share split

Grayscale's Zcash ETF (ZCSH) will undergo a 3-for-1 share split on Sept. 30, tripling shares without changing total value. Investors holding shares on Sept. 28 will receive two additional shares per existing share. The fund's assets grew rapidly since its Aug. 25 listing, reaching $890M by Sept. 17. ZCSH's price rose sharply before the split announcement, with ZEC also gaining.

$SYYMedAI 8/10

Debt Sale Could Be A Big Deal For Sysco Stock (SYY)

Sysco (SYY) completed a $1b equity offering and issued new fixed income securities, reshaping its capital structure for flexible funding. The company reaffirmed fiscal 2027 guidance of $90b in net sales, with 6-7% growth. Analysts forecast $96.1b revenue and $2.7b earnings by 2029. The move aims to support operations but also introduces balance sheet risks.